<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Gynecologic Oncology Group Notifies CTI That Continuation Of GOG&#45;212 Pivotal Trial Of OPAXIO Maintenance Therapy In  Ovarian Cancer Is A Priority</title>
	<atom:link href="http://rxlistblog.com/gynecologic-oncology-group-notifies-cti-that-continuation-of-gog212-pivotal-trial-of-opaxio-maintenance-therapy-in-ovarian-cancer-is-a-priority/feed/" rel="self" type="application/rss+xml" />
	<link>http://rxlistblog.com/gynecologic-oncology-group-notifies-cti-that-continuation-of-gog212-pivotal-trial-of-opaxio-maintenance-therapy-in-ovarian-cancer-is-a-priority/</link>
	<description>Medications and prescription drug information for consumers and medical health professionals. Prescription drug information and news for professionals and consumers.</description>
	<lastBuildDate></lastBuildDate>
	<generator>http://wordpress.org/?v=2.8</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	</channel>
</rss>

